These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15991303)

  • 1. Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease.
    Meng XW; Chi BR; Chen LG; Zhang LL; Zhuang Y; Huang HY; Sun X
    World J Gastroenterol; 2005 Jul; 11(25):3962-5. PubMed ID: 15991303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.
    Ohata K; Yano K; Yatsuhashi H; Daikoku M; Koga M; Eguchi K; Yano M
    Dig Dis Sci; 2004 Feb; 49(2):289-94. PubMed ID: 15104372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
    Chandra PK; Gunduz F; Hazari S; Kurt R; Panigrahi R; Poat B; Bruce D; Cohen AJ; Bohorquez HE; Carmody I; Loss G; Balart LA; Wu T; Dash S
    PLoS One; 2014; 9(9):e108616. PubMed ID: 25265476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
    Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
    Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type I IFN receptor].
    Hino K; Yamaguchi Y; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1351-5. PubMed ID: 11494550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha.
    Voltchek I; Sologub T; Nowicky JW; Grigoryeva T; Belozyorova L; Belopolskaya M; Semenyako N; Lamanova E
    Drugs Exp Clin Res; 2000; 26(5-6):261-6. PubMed ID: 11345036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
    Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
    J Gastroenterol Hepatol; 2017 Mar; 32(3):687-694. PubMed ID: 27577675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Oct; 79(10):1485-90. PubMed ID: 17705189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
    Pár A
    Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
    Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
    Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
    Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases.
    Ishimura N; Fukuda R; Fukumoto S
    J Gastroenterol Hepatol; 1996 Aug; 11(8):712-7. PubMed ID: 8872766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C.
    Noritake H; Kobayashi Y; Ooba Y; Matsunaga E; Ohta K; Shimoyama S; Yamazaki S; Chida T; Kawata K; Sakaguchi T; Suda T
    J Interferon Cytokine Res; 2015 Dec; 35(12):956-62. PubMed ID: 26308703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.